UPDATE : Friday, December 6, 2019
상단여백
GC MS wins US patent for influenza diagnostic technology by Lee Han-soo 2019-11-29 12:18
Hanmi's Chinese partner to start trials for anticancer treatment by Lee Han-soo 2019-11-28 17:38
GI Innovation licenses out immunotherapy drug candidate to Chinese firm by Lee Han-soo 2019-11-28 16:26
Takeda's ovarian cancer drug Zejula to get insurance benefit by Lee Han-soo 2019-11-28 15:36
ST Pharm submits IND application for colorectal cancer treatment in US by Lee Han-soo 2019-11-28 14:52
라인
Experts ascribe excessive diabetes hospitalization to lack of early treatment by Lee Han-soo 2019-11-28 11:26
Bristol-Myers Squibb Korea names new CEO by Lee Han-soo 2019-11-28 11:26
Daewoong ends P3 trial for drug treating gastroesophageal reflux disease by Lee Han-soo 2019-11-27 18:21
Vivozon stops short of meeting primary endpoint for P2b trial of nonnarcotic analgesics by Lee Han-soo 2019-11-26 18:48
Amgen releases analysis result showing benefits of LDL-C treatment by Lee Han-soo 2019-11-26 17:05
라인
'Type 2 diabetes mellitus patients have higher risk of dementia' by Lee Han-soo 2019-11-26 16:09
GC Labcell hands over NK cell-treating tech to US lab by Lee Han-soo 2019-11-26 15:33
SK Biopharm to speed up global advance through XCOPRI’s launch by Lee Han-soo 2019-11-26 14:16
Severance 1st Korean hospital to succeed in robot-assisted kidney transplant by Lee Han-soo 2019-11-25 18:00
Himchan Hospital opens Uzbekistan branch by Lee Han-soo 2019-11-25 16:54
라인
Huons Global wins KGMP certification for BTX plant by Lee Han-soo 2019-11-25 16:00
Gtree enrolls 200 patients for US trial of dry eye treatment by Lee Han-soo 2019-11-25 14:49
Daewoong renews EU GMP certification for BTX plant by Lee Han-soo 2019-11-25 11:55
SK Biopharm's antiepileptic drug is 1st local medicine to win FDA nod independently by Lee Han-soo 2019-11-22 17:03
‘Diabetes patients at higher risk of contracting infectious disease’ by Lee Han-soo 2019-11-22 16:02
여백
여백
여백
Back to Top